CDC: Precancerous cervical lesions on decline in young women
Precancerous cervical lesions associated with human papillomavirus declined sharply in women aged 18–24 between 2008 and 2016, likely reflecting increasing HPV vaccination and changes in detection of these lesions due to updated cervical cancer screening and management recommendations, the Centers for Disease Control and Prevention reported today. Screen-detected, high-grade cervical lesions develop within a few years after infection and have been used to monitor HPV vaccine impact because HPV-associated cancers typically take decades to develop. In 2006, HPV vaccine was licensed and recommended for girls aged 11-12 and for catch-up vaccination through age 26.
Related News Articles
Perspective
One year ago, a nurse at Children’s Hospital Colorado went above and beyond in a way that a very young patient and her family will never forget. Kayla…
Headline
The AHA voiced support for the Securing Access to Care for Seniors in Critical Condition Act (H.R.1924), legislation that would provide reimbursement for long-…
Headline
The Centers for Medicare & Medicaid Services April 10 announced that it does not intend to approve new or extend existing requests for federal funds to…
Headline
The AHA April 11 commented on the Centers for Medicare & Medicaid Services’ 2025 Marketplace Integrity and Affordability proposed rule. While the AHA…
Headline
A KFF analysis published April 3 found that Health Insurance Marketplace enrollment reached a record-high for a fourth consecutive year and has more than…
Perspective
Congress is back in Washington, D.C., for a critical three-week stretch in which House and Senate Republicans are seeking to strike a compromise on a common…